WAVEFORM INTELLIGENCE

What this means for you

This application is over — abandoned 30 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98550900

Mark type

Stylized text

Filed

14 May 2024

Abandoned

30 Apr 2025

Attorney of record

Amit Kulkarni

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Pressure measuring apparatus; Recorded Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Recorded Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for measuring and displaying the electrical signal produced by the heart; Software as a Medical Device (SaMD), downloadable, for the treatment of diabetes by monitoring glucose levels; Software as a Medical Device (SaMD), downloadable, for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for use as electrocardiographs; Software as a Medical Device (SaMD), recorded, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), recorded, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), recorded, for use as a medical instrument for vital sign monitoring
• Class 010 — Medical apparatus: Blood pressure and diabetic diagnostic medical devices; Computerized medical recording and analysis apparatus for the diagnosis and treatment of arrhythmias; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Diagnostic apparatus for medical purposes used in medical laboratories for testing vital signs; Manometers for medical purposes being arterial blood pressure measuring apparatus; Medical and surgical apparatus and instruments for use in vital sign monitoring procedures; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments for use in vital sign monitoring procedures; Medical apparatus and instruments relating to neurovegetative reactivity; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing suspected heart attacks; Medical apparatus for monitoring blood glucose levels; Medical apparatus for monitoring vital signs of patients; Medical apparatus for preventing or reversing heart failure; Medical apparatus for the treatment of respiratory conditions; Medical apparatus for use in treating abnormal vital signs; Medical apparatus, namely, fetal and maternal vital sign and physical distress monitors; Medical apparatus, namely, respiratory equipment and monitors therefor; Medical device used for the acquisition of physiological data for polysomnography; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of recorded software for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices for treating congestive heart failure; Medical devices for use in diagnosing abnormal vital signs; Medical devices for use in treating abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs with integrated recorded operating system software, sold as a unit; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, pulse generators for vital sign monitoring; Medical diagnostic apparatus for testing vital signs; Medical diagnostic apparatus for testing vital signs incorporating recorded operating system software; Medical imaging apparatus for use in the field of vital sign monitoring; Medical imaging apparatus for use in the field of vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus for vital sign monitoring; Medical imaging apparatus for vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus with embedded operating system software; Medical imaging devices for vital sign monitoring; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Surgical and medical apparatus and instruments for use in general surgery; Surgical and medical apparatus and instruments for use in vital sign monitoring during surgery; Ultrasound apparatus for medical purposes; Ultrasound apparatus for medical use; Arterial blood pressure measuring apparatus; Blood pressure measuring apparatus

Owner

• EMx Biotech LLC, Austin, TX, US

Prosecution history

• 15 May 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 15 May 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 29 Jan 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 29 Jan 2025 — FINAL REFUSAL E-MAILED
• 29 Jan 2025 — FINAL REFUSAL WRITTEN
• 25 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 24 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 24 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 24 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 24 Oct 2024 — NON-FINAL ACTION E-MAILED
• 24 Oct 2024 — NON-FINAL ACTION WRITTEN
• 24 Oct 2024 — ASSIGNED TO EXAMINER
• 15 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 15 May 2024 — NEW APPLICATION ENTERED